Nationwide Fund Advisors’s Aegerion Pharmaceuticals, Inc. AEGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-16,333
| Closed | -$60K | – | 3356 |
|
|
2016
Q1 | $60K | Hold |
16,333
| – | – | ﹤0.01% | 2953 |
|
|
2015
Q4 | $165K | Hold |
16,333
| – | – | ﹤0.01% | 2642 |
|
|
2015
Q3 | $222K | Hold |
16,333
| – | – | ﹤0.01% | 2509 |
|
|
2015
Q2 | $310K | Sell |
16,333
-5,311
| -25% | -$101K | ﹤0.01% | 2490 |
|
|
2015
Q1 | $566K | Sell |
21,644
-975
| -4% | -$25.5K | ﹤0.01% | 2177 |
|
|
2014
Q4 | $474K | Sell |
22,619
-206
| -0.9% | -$4.32K | ﹤0.01% | 2212 |
|
|
2014
Q3 | $762K | Sell |
22,825
-20,658
| -48% | -$690K | ﹤0.01% | 1966 |
|
|
2014
Q2 | $1.4M | Buy |
43,483
+21,229
| +95% | +$681K | 0.01% | 1689 |
|
|
2014
Q1 | $1.03M | Sell |
22,254
-18,339
| -45% | -$846K | ﹤0.01% | 1719 |
|
|
2013
Q4 | $2.88M | Sell |
40,593
-42,688
| -51% | -$3.03M | 0.01% | 1260 |
|
|
2013
Q3 | $7.14M | Buy |
83,281
+32,529
| +64% | +$2.79M | 0.03% | 701 |
|
|
2013
Q2 | $3.22M | Buy |
+50,752
| New | +$3.22M | 0.02% | 1048 |
|